Competition

  • October 02, 2026

    Onsemi, Synaptics Revise Deal To $5.7B After Alternate Bid

    Onsemi and Synaptics Inc. have amended their $7 billion merger agreement after a third party submitted an unsolicited competing bid for Synaptics, resulting in a revised $5.7 billion value and a switch from all-stock to cash.

  • October 02, 2026

    Roberts Wants Less Talk. Supreme Court Attorneys Disagree.

    Near the end of last term, Chief Justice John Roberts voiced his frustration with the U.S. Supreme Court's lengthening oral argument sessions and suggested the justices might tweak their format over the summer. But as the new term begins Monday, the court has yet to announce any changes, and advocates see little need for improvement.

  • October 02, 2026

    Taxation With Representation: Hogan Lovells, Davies, Sidley

    In this week's Taxation With Representation, semiconductor company Advanced Micro Devices buys AI model developer and research lab World Labs, Brixmor Property Group and private investment management firm Everview Partners acquire Slate Grocery REIT, and cyberintelligence company REDLattice merges with blank check company Bold Eagle Acquisition Corp.

  • October 02, 2026

    CMA Worries Nexfibre's $2.7B Deal Could Hinder Competition

    The competition regulator said Friday that it has provisionally found that the Nexfibre joint venture's proposed $2.7 billion acquisition of Substantial Group, the second-largest alternative fiber provider in the U.K., could harm competition in the country.

  • October 02, 2026

    5 Supreme Court Cases To Watch This Fall

    The U.S. Supreme Court will convene Monday to begin its 2026 October term, which includes several cases that could determine the future of climate change tort litigation, expand religious freedoms and parental rights, and grant states authority to require proof of citizenship when individuals register for presidential elections using state forms. 

  • October 02, 2026

    EU Court Upholds €31.5M Packaging Cartel Fines

    Two major canning companies have lost their appeals against €31.5 million ($35.5 million) in fines for participating in a cartel in Germany by sharing sales information and coordinating commercial strategies after an European Union court dismissed their arguments.

  • October 01, 2026

    Kraft Wheat Traders Lose Class Status, Keep Antitrust Claim

    Kraft Foods has convinced a Chicago federal judge to decertify two classes of investors and toss most of their decade-old claims accusing the food conglomerate and its snack food spinoff of manipulating wheat market commodities, but a jury will have to decide if it ran afoul of antitrust law.

  • October 01, 2026

    Quince Gets Williams Sonoma's False Ad Suit Axed For Now

    A California federal judge threw out Williams-Sonoma Inc.'s lawsuit accusing online retailer Quince of trying to dupe consumers into believing its goods are the same as Williams Sonoma's products at discounted prices, though the judge gave Williams Sonoma the opportunity to take another stab at its complaint.

  • October 01, 2026

    Visa, Mastercard Hit With Antitrust Suit Over Post-2019 Fees

    Even though Visa and Mastercard have paid out billions to escape litigation accusing them of plaguing merchants with predatory "swipe fees," the credit titans have not stopped inflating the fees businesses pay every time someone swipes their card, a new lawsuit alleges.

  • October 01, 2026

    Patients' Texas Anesthesia Rollup Suit Trimmed

    A Texas federal judge offered patients a mixed bag Wednesday in a proposed class action accusing U.S. Anesthesia Partners Inc. of anticompetitively buying up anesthesia practices in the state and fixing prices, dismissing claims based on ambulatory surgery center services while preserving allegations based on hospitals.

  • October 01, 2026

    AbbVie Gets Humira Antitrust Suit Trimmed, But Not Tossed

    An Illinois federal judge tossed all but one claim in a sheet metal worker health plan's putative class action against AbbVie for allegedly causing artificially inflated prices for the rheumatoid arthritis drug Humira, saying the plan sufficiently alleged AbbVie unlawfully stifled competition in the adalimumab market.

  • October 01, 2026

    Google Beats Online Publishers' AI Overviews Antitrust Suit

    A D.C. federal judge on Wednesday dismissed antitrust suits from Chegg Inc. and Penske Media Corp. against Google, finding that their central claims that the search engine giant coerces publishers into supplying free content for its artificial intelligence products "fail to get out of the starting gate." 

  • October 01, 2026

    Tennis Groups Can't Duck Players' Antitrust Suit

    A New York federal court has refused to toss a lawsuit brought by tennis players and a players association accusing tournament operators and the sport's governing bodies of blocking competition from rival tournaments.

  • October 01, 2026

    Merrill, But Not BofA, Must Face Cash Sweep Rates Suit

    Bank of America escaped account holders' allegations that they were paid unreasonably low interest rates under automatic cash sweep programs, but its wealth management division, Merrill Lynch, must still face most of the proposed class claims, according to a New York federal judge's ruling.

  • October 01, 2026

    Customers Ask 9th Circ. To Halt Paramount-Warner Bros. Deal

    Streaming service customers are asking the Ninth Circuit to step in and stop Paramount Skydance's planned $110 billion purchase of Warner Bros. Discovery until a court can decide if their antitrust suit challenging the merger will be dismissed.

  • October 01, 2026

    Google Ad Tech MDL Teed Up For Trial Largely Intact

    Gannett, the Daily Mail and a certified class of website publishers scored a major win with a New York federal court ruling largely refusing to let Google scrap antitrust allegations targeting its advertising placement technology business in sprawling multidistrict litigation.

  • October 01, 2026

    DOJ's RealPage Deal Doesn't End States' Antitrust Claims

    A North Carolina federal court has refused to toss antitrust claims from state enforcers accusing RealPage of providing software that allows residential building owners to inflate rents, despite RealPage's settlement in the case with the U.S. Department of Justice.

  • October 01, 2026

    Judge 'Flummoxed' By Forum Claim In IQVIA's Poaching Suit

    A North Carolina Business Court judge said Thursday that he was "flummoxed" by clinical research giant IQVIA Holdings Inc.'s argument for not enforcing its own forum selection clause against four top executives who decamped for a competitor.

  • October 01, 2026

    Ex-Actavis Exec Escapes Some Drug Price-Fixing Claims

    A Connecticut federal judge has dismissed a swath of claims against a former executive of Actavis and Taro in the generic drug price‑fixing litigation brought by state enforcers, holding that evidence was insufficient to prove he joined several alleged single‑drug conspiracies.

  • October 01, 2026

    Fed. Circ. Backs Galderma In Injection Training IP Case

    The Federal Circuit on Thursday affirmed an order clearing Galderma SA of a medical training startup's accusations that it misappropriated trade secrets related to an injection training system and derailed what could have been a lucrative deal with Allergan PLC.

  • October 01, 2026

    Janssen Secures Temporary Block Against Arthritis Biosimilar

    A Delaware federal judge has blocked Accord BioPharma from manufacturing a biosimilar version of Janssen's arthritis treatment Simponi while the Johnson & Johnson unit's patent lawsuit plays out.

  • October 01, 2026

    Google Shakes Suit Over Search Engine Default Agreements

    A proposed consumer class action accusing Google of monopolizing the online search market has been tossed by a California federal judge who said the plaintiffs didn't provide evidence showing that "better" options could have been available if Google hadn't struck default search engine deals with Apple and other companies.

  • October 01, 2026

    Monthly Merger Review Snapshot

    State enforcers settled their case challenging Paramount Skydance's planned $110 billion purchase of Warner Bros. Discovery, while the U.S. Department of Justice probes Fox's planned $22 billion deal for Roku and regulators review massive deals in the energy and railroad sectors.

  • October 01, 2026

    UK Antitrust Watchdog Greenlights E.ON's Acquisition Of Ovo

    Britain's competition regulator said Thursday it has cleared the planned acquisition by E.ON SE of retail energy supplier Ovo after carrying out an initial probe into the transaction.

  • September 30, 2026

    Paramount Gets OK On Deal With State AGs Over Merger

    A California federal judge gave the green light Wednesday to a settlement to end a group of state enforcers' challenge of Paramount Skydance's planned $110 billion purchase of Warner Bros. Discovery, saying the resolution reflects a "good faith approach" to alleviate concerns that the merger will stifle entertainment industry competition.

Expert Analysis

  • OhioHealth Suit Signals Higher Antitrust Heat On Hospitals

    Author Photo

    The recent antitrust lawsuit against OhioHealth by the U.S. Justice Department and Ohio attorney general shows that federal and state enforcers are closely examining the competition issues in the healthcare sector, including restrictive contracts and antisteering practices, say attorneys at Freshfields.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • 8 Tariff Refund Questions For Restructuring Professionals

    Author Photo

    For restructuring and turnaround professionals, seeking refunds following the U.S. Supreme Court's recent decision invalidating tariffs imposed under the International Emergency Economic Powers Act raises several questions about how to capture legitimate recoveries while protecting an enterprise from the consequences of its own history, says Jonny Frank and Laura Greenman at StoneTurn, and Andrew Popescu at Province.

  • Defense Deals Can Trigger Extra HSR Filing With The DOD

    Author Photo

    Certain aerospace, defense and national security M&A transactions will require a concurrent Hart-Scott-Rodino Act filing to the U.S. Department of Defense, and practice tips for navigating this extra filing include early analysis of competitive implications of sector deals and planning for concurrent filings, say attorneys at White & Case.

  • When Class Certification Issues And Crypto Nuance Collide

    Author Photo

    A New York federal court's recent ruling in In re: Tether and Bitfinex highlights that crypto companies should expect courts to apply conventional class action principles to novel digital asset markets, albeit with careful attention paid to the unique features of crypto trading, say attorneys at Duane Morris.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • Nippon Case Illustrates Challenges Of Proving Antitrust Injury

    Author Photo

    A recent California federal court decision dismissing challenges to Nippon Steel's purchase of U.S. Steel underscores the longtime antitrust precedent that while the limitations of injury are critical for defendants sued under U.S. antitrust laws, showing that the harm is real is the key, says Cameron Regnery at Freeman Mathis.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

  • When Trade Secret Litigation And Criminal Law Collide

    Author Photo

    An increasing convergence of trade secret litigation and white collar defense, especially with several recent criminal prosecutions from the Justice Department, should prompt businesses and counsel to adapt within the overlapping landscapes, says Kenneth Notter at MoloLamken.

  • What To Watch At The 2026 ABA Antitrust Spring Meeting

    Author Photo

    Attorneys at Freshfields consider the future of antitrust law and competition among developments likely to dominate discussion at the American Bar Association's Antitrust Spring Meeting this week.

  • And Now A Word From The Panel: New Rules For The JPML

    Author Photo

    On the heels of a new federal rule of civil procedure governing multidistrict litigation, the Judicial Panel on Multidistrict Litigation has adopted amendments to its own rules on subjects ranging from motions to seal to oral arguments — and it behooves panel practitioners to familiarize themselves with these changes, says Alan Rothman at Sidley.

  • 5 Tips For Navigating Your Firm's All-Attorney Summit

    Excerpt from Practical Guidance
    Author Photo

    Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.

  • Duke Energy Settlement Raises Key Antitrust Questions

    Author Photo

    The recent federal court settlement in Duke Energy v. NTE Carolinas II comes in the wake of the U.S. Supreme Court's failure to address a Fourth Circuit decision in the matter, calling into question the core purpose and effect of antitrust laws, say attorneys at Clifford Chance.

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • How Internal Reporting Could Benefit Antitrust Whistleblowing

    Author Photo

    As the Justice Department's new antitrust whistleblower program stands to raise questions over the interaction between rewards and corporate leniency, incentivizing internal reporting first could increase the likelihood that the Antitrust Division receives the high-quality evidence needed to successfully prosecute cartel cases, says Daniel Oakes at Axinn.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.